期刊文献+

曲古抑菌素A对前列腺癌LNCaP细胞抑制效应的细胞信号通路研究 被引量:5

Targeting multiple signaling pathways in LNCaP prostate cancer cell line by trichostatin A
下载PDF
导出
摘要 目的:研究组蛋白去乙酰化酶抑制剂曲古抑菌素A(TSA)对前列腺癌LNCaP细胞抑制作用的细胞信号机制。方法:半固体培养检测TSA对前列腺癌细胞集落形成能力的影响;Western Blot分析细胞蛋白乙酰化水平、细胞信号通路蛋白及细胞周期相关蛋白的表达。结果:TSA能够有效杀伤前列腺癌LNCaP细胞,在较低浓度即能抑制具有集落形成能力的细胞;药物处理使细胞内蛋白乙酰化水平增高,乙酰化组蛋白H3积累,多种细胞信号通路的相关蛋白如雄激素受体、HER2、Raf-1、Akt、CDK4等呈时间依赖性和剂量依赖性被清除。结论:TSA能够同时阻断对细胞生长具有重要作用的多条细胞信号通路,从而对前列腺癌LNCaP细胞发挥抑制作用。 AIM: To investigate the molecular mechanisms underlying the antitumor effect of trichostatin A (TSA) on LNCaP prostate cancer cells. METHODS: Colony formation analysis was performed to assay the effect of TSA on LNCaP colony forming ability. Western blotting was used to analyze protein acetylation standard as well as the expression of a panel of signaling molecules after TSA exposure. RESULTS: TSA inhibited the colony forming ability of LNCaP cells at a very low concentration. TSA exposure caused elevated acetylation of total cellular proteins as well as accumulation of acetylated-H3.In addition, signaling molecules which play key roles in prostate cancer such as AR, ErbB2, Raf-1, CDK4, and Akt were depleted by TSA in a dose and time-dependent manner. CONCLUSION: TSA exhibits significant antitumor activity against LNCaP cells by simultaneously interfering with multiple signaling pathways such as HER2/ MAPK, AR, and PI-3K-AKT pathways.
出处 《中国临床药理学与治疗学》 CAS CSCD 2006年第9期1013-1016,共4页 Chinese Journal of Clinical Pharmacology and Therapeutics
基金 国家自然科学基金重点项目(№30330620)
关键词 组蛋白脱乙酰基酶 前列腺癌 细胞信号通路 细胞凋亡 组蛋白去乙酰化酶抑制剂 曲古抑菌素A histone deacetylase prostate cancer signal transduction pathway cell apoptosis histone deacetylase inhibitors trichostatin A
  • 相关文献

参考文献9

  • 1Cress WD,Seto E.Histone deacetylases,transcriptional control,and cancer[J].J Cell Physiol,2000;184:1-16
  • 2Fronsdal K,Saatcioglu F.Histone deacetylase inhibitors differentially mediate apoptosis in prostate cancer cells[J].Prostate,2005;62:299-306
  • 3孙圣坤,刘兵,李秀森,侯春梅,洪宝发,于晓妉.曲古抑菌素A对前列腺癌LNCaP细胞雄激素受体的清除作用[J].中国临床药理学与治疗学,2005,10(11):1249-1252. 被引量:3
  • 4Zegarra-Moro OL,Schmidt LJ,Huang H,Tindall DJ.Disruption of androgen receptor function inhibits proliferation of androgen-refractory prostate cancer cells[J].Cancer Res,2002;62:1008-13
  • 5Abreu-Martin MT,Chari A,Palladino AA,Craft NA,Sawyers CL.Mitogen-activated protein kinase kinase kinase 1 activates androgen receptor-dependent transcription and apoptosis in prostate cancer[J].Mol Cell Biol,1999;19:5143-54
  • 6Lou W,Ni Z,Dyer K,Tweardy DJ,Gao AC.Interleukin-6 induces prostate cancer cell growth accompanied by activation of stat3 signaling pathway[J].Prostate,2000;42:239-42
  • 7McMenamin ME,Soung P,Perera S,Kaplan I,Loda M,Sellers WR.Loss of PTEN expression in paraffin-embedded primary prostate cancer correlates with high Gleason Score and advanced stage[J].Cancer Res,1999;59:4291-6
  • 8刘斌.肿瘤细胞的培养[A].见:司徒镇强,吴军正,主编.细胞培养[M].第1版.西安:世界图书出版公司,2004;189-234
  • 9Richy W,Johunstone.Histone-deacetylase inhibitors:novel drugs for the treatment of cancer[J].Nat Rev Drug Discov,2002;1:287-99

二级参考文献10

  • 1Cress WD,Seto E.Histone deacetylases,transcriptional control, and cancer[J].J Cell Physiol,2000;184:1-16
  • 2Fronsdal K,Saatcioglu F.Histone deacetylase inhibitors differentially mediate apoptosisin prostate cancer cells[J].Prostate,2005;62:299-306
  • 3Grossmann ME,Huang H,Tindall DJ.Androgen receptor signaling in androgen-refractoryprostate cancer[J].J Natl Cancer Inst,2001;93:1687-97
  • 4Koivisto P,Kononen J,Palmberg C,Tammela T,Hyytinen E,Isola J,et al.Androgen receptorgene amplification:a possible molecular mechanism for androgen deprivation therapy failurein prostate cancer[J]. Cancer Res,1997;57:314-9
  • 5Prins GS,Sklarew RJ,Pertschuk LP.Image analysis of androgen receptor immunostaining inprostate cancer accurately predicts response to hormonal therapy[J].J Urolo,1998;159:641-9
  • 6Tsurutani J,Soda H,Oka M,Suenaga M,Doi S,Nakamura Y,et al.Antiproliferative effects ofthe histone deacetylase inhibitor FR901228 on small-cell lung cancer lines and drug-resistant sublines[J].Int J Cancer,2003;104:238-42
  • 7Deroanne CF,Bonjean K,Servotte S,Devy L,Colige A,Clausse N,et al.Histone deacetylases inhibitors as anti-angiogenic agents altering vascular endothelial growth factor signaling[J].Oncogene,2002;21:427-36
  • 8Liu LT,Chang HC,Chiang LC,Hung WC.Histone Deacetylase Inhibitor Up-Regulates RECK to Inhibit MMP-2 Activation and Cancer Cell Invasion[J].Cancer Res,2003;63:3069-72
  • 9Boyes J,Byfield P,Nakatani Y,Ogryzko V. Regulation of activity of the transcription factor GATA-1 by acetylation[J].Nature,1998;396:594-8
  • 10Yu X,Guo ZS,Marcu MG,Neckers L,Nguyen DM,Chen GA,et al.Modulation ofp53,ErbB1,ErbB2,and Raf-1 expression in lung cancer cells by depsipeptide FR901228[J].JNatl Cancer Inst,2002;94:504-13

共引文献2

同被引文献26

  • 1阙华发,陈红风,徐杰男,刘胜,陆德铭,唐汉钧.生命质量与中医药治疗恶性肿瘤临床疗效评价标准探讨[J].中西医结合学报,2005,3(4):253-256. 被引量:33
  • 2孙圣坤,刘兵,李秀森,侯春梅,洪宝发,于晓妉.曲古抑菌素A对前列腺癌LNCaP细胞雄激素受体的清除作用[J].中国临床药理学与治疗学,2005,10(11):1249-1252. 被引量:3
  • 3邱志磊,牛海涛,孙光.2005年欧洲泌尿外科会议前列腺癌诊断治疗指南[J].国际泌尿系统杂志,2006,26(5):583-586. 被引量:25
  • 4米永杰,李健.中药血清药理学研究概述[J].四川解剖学杂志,2006,14(4):34-35. 被引量:32
  • 5Greenlee RT, Hill-Harmon MB, Murray T, et al. Cancer statistics[J]. CA Cancer J Clin, 2001, 51 (1)..15-36.
  • 6Fronsdal K,Saatcioglu F.Histone deacetylase inhibitors differentially mediate apoptosis in prostate cancer cells[J].Prostate,2005;62:299-306.
  • 7Ueda H,Manda T,Matsumoto S,et al.FR901228,a novel antitumor bicyclic depsipeptide produced by Chromobacterium violaceum No.968.III.Antitumor activities on experimental tumors in mice[J].J Antibiot (Tokyo),1994;47:315-323.
  • 8Weiser TS,Guo ZS,Ohnmacht GA,et al.Sequential 5-Aza-2 deoxycytidine-depsipeptide FR901228 treatment induces apoptosis preferentially in cancer cells and facilitates their recognition by cytolytic T lymphocytes specific for NY-ESO-1[J].J Immunother,2001;24:151-161.
  • 9Marks PA,Dokmanovic M.Histone deacetylase inhibitors:discovery and development as anticancer agents[J].Expert Opin Investig Drugs,2005;14:1497-1511.
  • 10Yu X,Guo ZS,Marcu MG,et al.Modulation of p53,ErbB1,ErbB2,and Raf-1 expression in lung cancer cells by depsipeptide FR901228[J].J Natl Cancer Inst,2002;94:504-513.

引证文献5

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部